Immediate Impact
8 standout
Citing Papers
Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
2021 Standout
Management of Rheumatoid Arthritis: An Overview
2021 Standout
Works of Michael Holers being referenced
The human complement receptor type 2 (CR2)/CR1 fusion protein TT32, a targeted inhibitor of the classical and alternative pathway C3 convertases, prevents arthritis in active immunization and passive transfer models and acts by CR2-dependent targeting of CR1 regulatory activity
2012
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Michael Holers | 2 | 15 | 4 | 4 | 15 | |||
| Selket Delafontaine | 2 | 11 | 2 | 5 | 16 | |||
| Guillaume Jeantet | 2 | 9 | 1 | 2 | 13 | |||
| Alex Dinh | 2 | 12 | 1 | 5 | 17 | |||
| Céline Comparon | 6 | 1 | 4 | 11 | ||||
| Ben S. Barksby | 4 | 8 | 2 | 12 | ||||
| Marilyn Wang | 3 | 1 | 9 | 4 | 18 | |||
| Vasant Chinnabhandar | 1 | 12 | 5 | 16 | ||||
| Elisa Hernández-Brito | 3 | 1 | 14 | 4 | 19 | |||
| Anahita Agharahimi | 1 | 10 | 3 | 13 | ||||
| Zhengliang Yue | 3 | 15 | 4 | 18 |
All Works
Loading papers...